Clinical Trial Update: A Study of Single and Multiple Doses of Rabeprazole in Pediatric Patients With Gastroesophageal Reflux Disease (GERD) 1 to 11 Months Old, Inclusive [Phase 1]

View source ↗

Summary

A completed Phase 1 trial evaluating single and multiple doses of rabeprazole in infants aged 1 to 11 months with gastroesophageal reflux disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease

Drugs mentioned

• Rabeprazole (rabeprazole)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Gastroesophageal Reflux Disease (GERD) | Phase 1 | Status: COMPLETED